Hvivo PLC (LON:HVO) insider Trevor Phillips bought 9,035 shares of the company’s stock in a transaction dated Thursday, December 14th. The stock was bought at an average price of GBX 56 ($0.75) per share, for a total transaction of £5,059.60 ($6,809.69).

Shares of Hvivo PLC (LON:HVO) opened at GBX 54 ($0.73) on Friday. Hvivo PLC has a 52-week low of GBX 50 ($0.67) and a 52-week high of GBX 239.75 ($3.23).

Hvivo (LON:HVO) last announced its earnings results on Thursday, September 21st. The company reported GBX (9.90) (($0.13)) earnings per share (EPS) for the quarter. The company had revenue of GBX 392 million during the quarter. Hvivo had a negative net margin of 196.81% and a negative return on equity of 36.48%.

Separately, Numis Securities lowered shares of Hvivo to a “hold” rating and set a GBX 80 ($1.08) target price on the stock. in a research report on Thursday, September 21st.

COPYRIGHT VIOLATION WARNING: “Insider Buying: Hvivo PLC (HVO) Insider Acquires £5,059.60 in Stock” was first reported by Watch List News and is the property of of Watch List News. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The original version of this news story can be accessed at https://www.watchlistnews.com/insider-buying-hvivo-plc-hvo-insider-acquires-5059-60-in-stock/1768785.html.

About Hvivo

hVIVO plc, formerly Retroscreen Virology Group plc, is a holding company. The Company is engaged in a life sciences business pioneering a technology platform of human disease models to accelerate drug discovery and development in respiratory and infectious diseases, including flu, respiratory syncytial virus (RSV), asthma and common cold.

Receive News & Ratings for Hvivo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hvivo and related companies with MarketBeat.com's FREE daily email newsletter.